APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endoparasiticide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Endoparasiticide Industry Growth and Trends Forecast to 2032

31 December 2025105 pages

Choose your research edition.

Industry ResearchEndoparasiticide Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Endoparasiticide Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Endoparasiticide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endoparasiticide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Endoparasiticide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Endoparasiticide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endoparasiticide include Novartis AG, Merck, Eli Lilly, Bayer AG, Zoetis, Virbac, Vetoquinol, Elanco and Ceva Sante Animlae, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Endoparasiticide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Endoparasiticide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endoparasiticide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endoparasiticide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Endoparasiticide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Endoparasiticide Market by Company

Novartis AG

Merck

Eli Lilly

Bayer AG

Zoetis

Virbac

Vetoquinol

Elanco

Ceva Sante Animlae

Boehringer Ingelheim

Endoparasiticide Segment by Type

Ear Tags

Feed Additives

Tablets

Injectables

Endoparasiticide Segment by Application

Veterinary Hospitals or Clinics

Home Care Settings

Animal Farms

Endoparasiticide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endoparasiticide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endoparasiticide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endoparasiticide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endoparasiticide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Endoparasiticide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ear Tags Table 2. Major Company of Feed Additives Table 3. Major Company of Tablets Table 4. Major Company of Injectables Table 5. Global Endoparasiticide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 7. Global Endoparasiticide Sales Market Share in Volume by Type (2021-2026) Table 8. Global Endoparasiticide Sales by Type (2021-2026) & (US$ Million) Table 9. Global Endoparasiticide Sales Market Share in Value by Type (2021-2026) Table 10. Global Endoparasiticide Price by Type (2021-2026) & (US$/Unit) Table 11. Global Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 12. Global Endoparasiticide Sales Market Share in Volume by Type (2027-2032) Table 13. Global Endoparasiticide Sales by Type (2027-2032) & (US$ Million) Table 14. Global Endoparasiticide Sales Market Share in Value by Type (2027-2032) Table 15. Global Endoparasiticide Price by Type (2027-2032) & (US$/Unit) Table 16. North America Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 17. North America Endoparasiticide Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 19. Europe Endoparasiticide Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Endoparasiticide Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 23. Latin America Endoparasiticide Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Endoparasiticide Sales by Type (2021-2026) & (US$ Million) Table 26. Endoparasiticide Industry Trends Table 27. Endoparasiticide Industry Drivers Table 28. Endoparasiticide Industry Opportunities and Challenges Table 29. Endoparasiticide Industry Restraints Table 30. Global Endoparasiticide Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Endoparasiticide Revenue Market Share by Company (2021-2026) Table 32. Global Endoparasiticide Sales by Company (2021-2026) & (K Units) Table 33. Global Endoparasiticide Sales Share by Company (2021-2026) Table 34. Global Endoparasiticide Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Endoparasiticide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Endoparasiticide Major Company Production Sites and Headquarters Table 37. Global Endoparasiticide Company, Product Type & Application Table 38. Global Endoparasiticide Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Endoparasiticide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Endoparasiticide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Endoparasiticide Sales by Region (2021-2026) & (K Units) Table 43. Global Endoparasiticide Sales Market Share in Volume by Region (2021-2026) Table 44. Global Endoparasiticide Sales by Region (2021-2026) & (US$ Million) Table 45. Global Endoparasiticide Sales Market Share in Value by Region (2021-2026) Table 46. Global Endoparasiticide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Endoparasiticide Sales by Region (2027-2032) & (K Units) Table 48. Global Endoparasiticide Sales Market Share in Volume by Region (2027-2032) Table 49. Global Endoparasiticide Sales by Region (2027-2032) & (US$ Million) Table 50. Global Endoparasiticide Sales Market Share in Value by Region (2027-2032) Table 51. Global Endoparasiticide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Endoparasiticide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 54. Global Endoparasiticide Sales Market Share in Volume by Application (2021-2026) Table 55. Global Endoparasiticide Sales by Application (2021-2026) & (US$ Million) Table 56. Global Endoparasiticide Sales Market Share in Value by Application (2021-2026) Table 57. Global Endoparasiticide Price by Application (2021-2026) & (US$/Unit) Table 58. Global Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 59. Global Endoparasiticide Sales Market Share in Volume by Application (2027-2032) Table 60. Global Endoparasiticide Sales by Application (2027-2032) & (US$ Million) Table 61. Global Endoparasiticide Sales Market Share in Value by Application (2027-2032) Table 62. Global Endoparasiticide Price by Application (2027-2032) & (US$/Unit) Table 63. North America Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 64. North America Endoparasiticide Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 66. Europe Endoparasiticide Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Endoparasiticide Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 70. Latin America Endoparasiticide Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Endoparasiticide Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novartis AG Endoparasiticide Product Portfolio Table 77. Novartis AG Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck Endoparasiticide Product Portfolio Table 82. Merck Recent Development Table 83. Eli Lilly Company Information Table 84. Eli Lilly Business Overview Table 85. Eli Lilly Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Eli Lilly Endoparasiticide Product Portfolio Table 87. Eli Lilly Recent Development Table 88. Bayer AG Company Information Table 89. Bayer AG Business Overview Table 90. Bayer AG Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bayer AG Endoparasiticide Product Portfolio Table 92. Bayer AG Recent Development Table 93. Zoetis Company Information Table 94. Zoetis Business Overview Table 95. Zoetis Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Zoetis Endoparasiticide Product Portfolio Table 97. Zoetis Recent Development Table 98. Virbac Company Information Table 99. Virbac Business Overview Table 100. Virbac Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Virbac Endoparasiticide Product Portfolio Table 102. Virbac Recent Development Table 103. Vetoquinol Company Information Table 104. Vetoquinol Business Overview Table 105. Vetoquinol Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Vetoquinol Endoparasiticide Product Portfolio Table 107. Vetoquinol Recent Development Table 108. Elanco Company Information Table 109. Elanco Business Overview Table 110. Elanco Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Elanco Endoparasiticide Product Portfolio Table 112. Elanco Recent Development Table 113. Ceva Sante Animlae Company Information Table 114. Ceva Sante Animlae Business Overview Table 115. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Ceva Sante Animlae Endoparasiticide Product Portfolio Table 117. Ceva Sante Animlae Recent Development Table 118. Boehringer Ingelheim Company Information Table 119. Boehringer Ingelheim Business Overview Table 120. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim Endoparasiticide Product Portfolio Table 122. Boehringer Ingelheim Recent Development Table 123. North America Endoparasiticide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 125. North America Endoparasiticide Sales Market Share by Country (2021-2026) Table 126. North America Endoparasiticide Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Endoparasiticide Sales Market Share Forecast by Country (2027-2032) Table 128. North America Endoparasiticide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Endoparasiticide Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Endoparasiticide Market Share by Country (2021-2026) Table 131. North America Endoparasiticide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Endoparasiticide Market Share Forecast by Country (2027-2032) Table 133. Europe Endoparasiticide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 135. Europe Endoparasiticide Sales Market Share by Country (2021-2026) Table 136. Europe Endoparasiticide Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Endoparasiticide Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Endoparasiticide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Endoparasiticide Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Endoparasiticide Market Share by Country (2021-2026) Table 141. Europe Endoparasiticide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Endoparasiticide Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Endoparasiticide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Endoparasiticide Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Endoparasiticide Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Endoparasiticide Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Endoparasiticide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Endoparasiticide Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Endoparasiticide Market Share by Country (2021-2026) Table 151. Asia-Pacific Endoparasiticide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Endoparasiticide Market Share Forecast by Country (2027-2032) Table 153. Latin America Endoparasiticide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 155. Latin America Endoparasiticide Sales Market Share by Country (2021-2026) Table 156. Latin America Endoparasiticide Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Endoparasiticide Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Endoparasiticide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Endoparasiticide Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Endoparasiticide Market Share by Country (2021-2026) Table 161. Latin America Endoparasiticide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Endoparasiticide Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Endoparasiticide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Endoparasiticide Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Endoparasiticide Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Endoparasiticide Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Endoparasiticide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Endoparasiticide Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Endoparasiticide Market Share by Country (2021-2026) Table 171. Middle East and Africa Endoparasiticide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Endoparasiticide Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Endoparasiticide Distributors List Table 176. Endoparasiticide Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Endoparasiticide Image Figure 2. Global Endoparasiticide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endoparasiticide Market Size (2021-2032) & (US$ Million) Figure 4. Global Endoparasiticide Sales (2021-2032) & (K Units) Figure 5. Ear Tags Image Figure 6. Global Ear Tags Sales YoY Growth (2021-2032) & (K Units) Figure 7. Feed Additives Image Figure 8. Global Feed Additives Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tablets Image Figure 10. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 11. Injectables Image Figure 12. Global Injectables Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Endoparasiticide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Endoparasiticide Market Share by Type 2025 VS 2032 Figure 15. North America Endoparasiticide Sales Market Share in Volume by Type in 2025 Figure 16. North America Endoparasiticide Sales Market Share in Value by Type in 2025 Figure 17. Europe Endoparasiticide Sales Market Share in Volume by Type in 2025 Figure 18. Europe Endoparasiticide Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Endoparasiticide Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Endoparasiticide Sales Market Share in Value by Type in 2025 Figure 21. Latin America Endoparasiticide Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Endoparasiticide Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Endoparasiticide Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Endoparasiticide Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Endoparasiticide Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Veterinary Hospitals or Clinics Image Figure 28. Global Veterinary Hospitals or Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Home Care Settings Image Figure 30. Global Home Care Settings Sales YoY Growth (2021-2032) & (K Units) Figure 31. Animal Farms Image Figure 32. Global Animal Farms Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Endoparasiticide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Endoparasiticide Market Share by Application 2025 VS 2032 Figure 35. North America Endoparasiticide Sales Market Share in Volume by Application in 2025 Figure 36. North America Endoparasiticide Sales Market Share in Value by Application in 2025 Figure 37. Europe Endoparasiticide Sales Market Share in Volume by Application in 2025 Figure 38. Europe Endoparasiticide Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Endoparasiticide Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Endoparasiticide Sales Market Share in Value by Application in 2025 Figure 41. Latin America Endoparasiticide Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Endoparasiticide Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Endoparasiticide Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Endoparasiticide Sales Market Share in Value by Application in 2025 Figure 45. North America Endoparasiticide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Endoparasiticide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Endoparasiticide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Endoparasiticide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Endoparasiticide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Endoparasiticide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Endoparasiticide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Endoparasiticide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Endoparasiticide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Endoparasiticide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Endoparasiticide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Endoparasiticide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Endoparasiticide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Endoparasiticide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Endoparasiticide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Endoparasiticide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Endoparasiticide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Endoparasiticide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Endoparasiticide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Endoparasiticide Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Endoparasiticide Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Endoparasiticide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ear Tags
  • Feed Additives
  • Tablets
  • Injectables
Applications
  • Veterinary Hospitals or Clinics
  • Home Care Settings
  • Animal Farms
Companies covered
  • Novartis AG
  • Merck
  • Eli Lilly
  • Bayer AG
  • Zoetis
  • Virbac
  • Vetoquinol
  • Elanco
  • Ceva Sante Animlae
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endoparasiticide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Endoparasiticide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Endoparasiticide Market by Type
  6. 1.3.1 Ear Tags
  7. 1.3.2 Feed Additives
  8. 1.3.3 Tablets
  9. 1.3.4 Injectables
  10. 1.4 Global Endoparasiticide Market Size by Type
  11. 1.4.1 Global Endoparasiticide Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Endoparasiticide Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Endoparasiticide Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Endoparasiticide Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Endoparasiticide Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Endoparasiticide Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Endoparasiticide Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Endoparasiticide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Endoparasiticide Industry Trends
  2. 2.2 Endoparasiticide Industry Drivers
  3. 2.3 Endoparasiticide Industry Opportunities and Challenges
  4. 2.4 Endoparasiticide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Endoparasiticide Revenue (2021-2026)
  2. 3.2 Global Top Players by Endoparasiticide Sales (2021-2026)
  3. 3.3 Global Top Players by Endoparasiticide Price (2021-2026)
  4. 3.4 Global Endoparasiticide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endoparasiticide Major Company Production Sites & Headquarters
  6. 3.6 Global Endoparasiticide Company, Product Type & Application
  7. 3.7 Global Endoparasiticide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endoparasiticide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endoparasiticide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endoparasiticide Tier 1, Tier 2, and Tier 3
4 Endoparasiticide Regional Status and Outlook
  1. 4.1 Global Endoparasiticide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Endoparasiticide Historic Market Size by Region
  3. 4.2.1 Global Endoparasiticide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Endoparasiticide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Endoparasiticide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Endoparasiticide Forecasted Market Size by Region
  7. 4.3.1 Global Endoparasiticide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Endoparasiticide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Endoparasiticide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Endoparasiticide by Application
  1. 5.1 Endoparasiticide Market by Application
  2. 5.1.1 Veterinary Hospitals or Clinics
  3. 5.1.2 Home Care Settings
  4. 5.1.3 Animal Farms
  5. 5.2 Global Endoparasiticide Market Size by Application
  6. 5.2.1 Global Endoparasiticide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Endoparasiticide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Endoparasiticide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Endoparasiticide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Endoparasiticide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Endoparasiticide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Endoparasiticide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Endoparasiticide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Endoparasiticide Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Endoparasiticide Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Endoparasiticide Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Endoparasiticide Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Zoetis
  26. 6.5.1 Zoetis Company Information
  27. 6.5.2 Zoetis Business Overview
  28. 6.5.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zoetis Endoparasiticide Product Portfolio
  30. 6.5.5 Zoetis Recent Developments
  31. 6.6 Virbac
  32. 6.6.1 Virbac Company Information
  33. 6.6.2 Virbac Business Overview
  34. 6.6.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Virbac Endoparasiticide Product Portfolio
  36. 6.6.5 Virbac Recent Developments
  37. 6.7 Vetoquinol
  38. 6.7.1 Vetoquinol Company Information
  39. 6.7.2 Vetoquinol Business Overview
  40. 6.7.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vetoquinol Endoparasiticide Product Portfolio
  42. 6.7.5 Vetoquinol Recent Developments
  43. 6.8 Elanco
  44. 6.8.1 Elanco Company Information
  45. 6.8.2 Elanco Business Overview
  46. 6.8.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Elanco Endoparasiticide Product Portfolio
  48. 6.8.5 Elanco Recent Developments
  49. 6.9 Ceva Sante Animlae
  50. 6.9.1 Ceva Sante Animlae Company Information
  51. 6.9.2 Ceva Sante Animlae Business Overview
  52. 6.9.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ceva Sante Animlae Endoparasiticide Product Portfolio
  54. 6.9.5 Ceva Sante Animlae Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Endoparasiticide Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Endoparasiticide Sales by Country
  2. 7.1.1 North America Endoparasiticide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Endoparasiticide Sales by Country (2021-2026)
  4. 7.1.3 North America Endoparasiticide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Endoparasiticide Market Size by Country
  6. 7.2.1 North America Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Endoparasiticide Market Size by Country (2021-2026)
  8. 7.2.3 North America Endoparasiticide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Endoparasiticide Sales by Country
  2. 8.1.1 Europe Endoparasiticide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Endoparasiticide Sales by Country (2021-2026)
  4. 8.1.3 Europe Endoparasiticide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Endoparasiticide Market Size by Country
  6. 8.2.1 Europe Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Endoparasiticide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Endoparasiticide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Endoparasiticide Sales by Country
  2. 9.1.1 Asia-Pacific Endoparasiticide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Endoparasiticide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Endoparasiticide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Endoparasiticide Market Size by Country
  6. 9.2.1 Asia-Pacific Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Endoparasiticide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Endoparasiticide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Endoparasiticide Sales by Country
  2. 10.1.1 South America Endoparasiticide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Endoparasiticide Sales by Country (2021-2026)
  4. 10.1.3 South America Endoparasiticide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Endoparasiticide Market Size by Country
  6. 10.2.1 South America Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Endoparasiticide Market Size by Country (2021-2026)
  8. 10.2.3 South America Endoparasiticide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Endoparasiticide Sales by Country
  2. 11.1.1 Middle East and Africa Endoparasiticide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Endoparasiticide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Endoparasiticide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Endoparasiticide Market Size by Country
  6. 11.2.1 Middle East and Africa Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Endoparasiticide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Endoparasiticide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Endoparasiticide Value Chain Analysis
  2. 12.1.1 Endoparasiticide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Endoparasiticide Production Mode & Process
  7. 12.2 Endoparasiticide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Endoparasiticide Distributors
  10. 12.2.3 Endoparasiticide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst